Sustained Hematological Stability During Clozapine Rechallenge With Adjunctive Lithium: A Case Report of 15-Month Follow-Up
Karim Hamda, Azeddine Barkiat, Siham Belbachir, Abderrazzak Ouanass · 2026
Read Sustained Hematological Stability During Clozapine Rechallenge With Adjunctive Lithium: A Case Report of 15-Month Follow-Up by Karim Hamda, Azeddine Barkiat, Siham Belbachir, Abderrazzak Ouanass (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13268217.txt.
Description
Karim Hamda and co-authors report a fifteen-month case of clozapine restart with lithium cover in a 2026 paper. Clozapine is the best drug for schizophrenia that resists other drugs, but it can crash white blood cell counts.
A man in his early thirties had stopped clozapine after a past count crash and failed other drugs. Doctors restarted it with low-dose lithium, which can lift white cell output. Twenty-five blood counts over the follow-up stayed in safe ranges, with no low-count episode. Counts showed no slide over time, and lithium levels stayed low. The case supports careful restart with lithium cover under close blood watch.
Catalog record
| CREATOR | Karim Hamda, Azeddine Barkiat, Siham Belbachir, Abderrazzak Ouanass |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 9 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |